416 related articles for article (PubMed ID: 17667863)
1. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
2. Obesity: a central risk and cardiovascular target of the cardiometabolic syndrome.
Frohlich ED
J Cardiometab Syndr; 2008; 3(3):147-8. PubMed ID: 18983330
[No Abstract] [Full Text] [Related]
3. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
4. Obesity and cardiometabolic syndrome in children.
Velasquez-Mieyer P; Neira CP; Nieto R; Cowan PA
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):61-81. PubMed ID: 19124396
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic options for modifying cardiometabolic risk factors.
Aronne LJ
Am J Med; 2007 Mar; 120(3 Suppl 1):S26-34. PubMed ID: 17320519
[TBL] [Abstract][Full Text] [Related]
6. The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
Schindler C
Ther Adv Cardiovasc Dis; 2007 Oct; 1(1):7-26. PubMed ID: 19124392
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
8. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health and Nutrition Examination Survey, 1999 to 2004.
Nguyen NT; Magno CP; Lane KT; Hinojosa MW; Lane JS
J Am Coll Surg; 2008 Dec; 207(6):928-34. PubMed ID: 19183541
[TBL] [Abstract][Full Text] [Related]
9. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
10. Challenges and strategies in managing cardiometabolic risk.
Repas TB
J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S4-11. PubMed ID: 17784529
[TBL] [Abstract][Full Text] [Related]
11. Potential role of new therapies in modifying cardiovascular risk in overweight patients with metabolic risk factors.
Jensen MD
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():143S-149S. PubMed ID: 16931496
[TBL] [Abstract][Full Text] [Related]
12. The medical cost of cardiometabolic risk factor clusters in the United States.
Sullivan PW; Ghushchyan V; Wyatt HR; Hill JO
Obesity (Silver Spring); 2007 Dec; 15(12):3150-8. PubMed ID: 18198326
[TBL] [Abstract][Full Text] [Related]
13. Obesity: new perspectives and pharmacotherapies.
Palamara KL; Mogul HR; Peterson SJ; Frishman WH
Cardiol Rev; 2006; 14(5):238-58. PubMed ID: 16924165
[TBL] [Abstract][Full Text] [Related]
14. The cardiometabolic syndrome in the adolescent.
Gardner M; Gardner DW; Sowers JR
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():964-8. PubMed ID: 18806711
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome: epidemiology and consequences.
Sacks FM
J Clin Psychiatry; 2004; 65 Suppl 18():3-12. PubMed ID: 15600380
[TBL] [Abstract][Full Text] [Related]
16. Reducing cardiovascular risk in metabolic syndrome and type 2 diabetes mellitus beyond low-density lipoprotein cholesterol lowering: a role for fenofibrate. Introduction.
Sacks FM
Am J Cardiol; 2008 Dec; 102(12A):1L-3L. PubMed ID: 19084082
[No Abstract] [Full Text] [Related]
17. Management of obesity: medical treatment options.
Carek PJ; Sherer JT; Carson DS
Am Fam Physician; 1997 Feb; 55(2):551-8, 561-2. PubMed ID: 9054224
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and cardiovascular disease.
Qiao Q; Gao W; Zhang L; Nyamdorj R; Tuomilehto J
Ann Clin Biochem; 2007 May; 44(Pt 3):232-63. PubMed ID: 17456293
[TBL] [Abstract][Full Text] [Related]
19. Obesity and abdominal obesity; an alarming challenge for cardio-metabolic risk in Turkish adults.
Oğuz A; Temizhan A; Abaci A; Kozan O; Erol C; Ongen Z; Celik S
Anadolu Kardiyol Derg; 2008 Dec; 8(6):401-6. PubMed ID: 19103534
[TBL] [Abstract][Full Text] [Related]
20. Screen detection and the WHO stepwise approach to the prevalence and risk factors of arterial hypertension in Kinshasa.
Longo-Mbenza B; Ngoma DV; Nahimana D; Mayuku DM; Fuele SM; Ekwanzala F; Beya C
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):503-8. PubMed ID: 18830083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]